We are live on ! Find out more
ALZN icon

Alzamend Neuro
ALZN

8 hedge funds and large institutions have $2.58M invested in Alzamend Neuro in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$1.28M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$542K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$426K
4
CSS
Cubist Systematic Strategies
Connecticut
+$232K
5
TSS
Two Sigma Securities
New York
+$155K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$1.17M +$1.28M +99 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$498K +$542K +42 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$389K +$426K +33 New
CSS
4
Cubist Systematic Strategies
Connecticut
$207K +$232K +18 New
TSS
5
Two Sigma Securities
New York
$140K +$155K +12 New
VF
6
Virtu Financial
New York
$135K +$142K +11 New
UBS Group
7
UBS Group
Switzerland
$24K +$25.8K +2 New
TRCT
8
Tower Research Capital (TRC)
New York
$18K +$25.8K +2 New
Morgan Stanley
9
Morgan Stanley
New York
$2K – – –
Wells Fargo
10
Wells Fargo
California
$2K – – –

ALZN Hedge Fund Activity: Q2 2021 in Review

8 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q2 2021, worth a combined $2.58M.

Buyers outnumbered sellers: 8 funds opened new ALZN positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $1.28M.

  • 8 institutional investors held Alzamend Neuro (ALZN) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $2.58M of Alzamend Neuro stock for Q2 2021.
  • 8 funds opened new Alzamend Neuro positions in Q2 2021 and 0 closed out, a net change of +8 holders.
  • The largest Alzamend Neuro buyer in Q2 2021 was Jane Street, an estimated $1.28M added.

Based on aggregated 13F filings for Q2 2021.